» Articles » PMID: 32749898

Epidemiology and Risk Factors for Eosinophilic Esophagitis: Lessons for Clinicians

Overview
Specialty Gastroenterology
Date 2020 Aug 5
PMID 32749898
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: The rapid expansion in the epidemiology of eosinophilic esophagitis (EoE) is being documented, along with cumulative research assessing environmental exposures associated with EoE and susceptibility due to genetic variants.

Areas Covered: Incidence rates for EoE of 5-10 new cases per 100,000 inhabitants annually have shown an increase in recent reports of up to 20 in some countries; the highest prevalence being reported for Europe and North America, where EoE now affects more than 1 out of 1,000 people. EoE has been shown to be associated with several disorders, Th2-mediated atopies being the most common. Patients with EoE exhibit increased frequency of asthma, allergic rhinitis and eczema, and EoE has been considered as a late component of the atopic march. Risk variants in and genes, among others, have all been related to EoE, and interact with prenatal and early life exposure potentially modifying abundance and composition of gut microbiome. Dysregulated interactions between bacteria and mucosal immunity emerge as leading causes of EoE.

Expert Opinion: The expanding epidemiology of EoE, the resources needed and subsequent increasing healthcare costs require additional effort to optimize cost-effective management and unveil mechanisms that enhance the development of future preventive strategies.

Citing Articles

Eosinophilic esophagitis in children: A multicenter study evaluating current practices in Mexico.

Gonzalez-Uribe V, Hernandez-Zarate L, Pozo Beltran C, Alcocer-Arreguin C, de Baro Alvarez P, Coello-Niembro N J Allergy Clin Immunol Glob. 2025; 4(1):100392.

PMID: 39989670 PMC: 11846429. DOI: 10.1016/j.jacig.2024.100392.


Eosinophilic esophagitis in the "atopic march": dupilumab as an "umbrella" strategy for multiple coexisting atopic diseases.

Lutzu N, Favale A, Demurtas M, Del Giacco S, Onali S, Fantini M Front Med (Lausanne). 2025; 11:1513417.

PMID: 39906352 PMC: 11790572. DOI: 10.3389/fmed.2024.1513417.


MicroRNAs in Plasma-Derived Extracellular Vesicles as Non-Invasive Biomarkers for Eosinophilic Esophagitis.

Grueso-Navarro E, Rodriguez-Alcolado L, Arias-Gonzalez L, Aransay A, Lozano J, Sidorova J Int J Mol Sci. 2025; 26(2).

PMID: 39859353 PMC: 11766357. DOI: 10.3390/ijms26020639.


Psychometric evaluation of the Dysphagia Symptom Questionnaire for adults and adolescents with eosinophilic esophagitis.

McCann E, Peterson K, Whalley D, Qin S, Tilton S, Kamat S J Allergy Clin Immunol Glob. 2024; 3(4):100302.

PMID: 39228895 PMC: 11369371. DOI: 10.1016/j.jacig.2024.100302.


Dietary Treatment for Children and Adults with Eosinophilic Esophagitis: Which Patient and Which Doctor Is It Suitable for?.

Chahuan J, Lucendo A Inflamm Intest Dis. 2024; 9(1):184-198.

PMID: 39144838 PMC: 11324268. DOI: 10.1159/000540228.